Scarica l'app Stockscreener
4.14
2.99%
0.12
Dopo l'orario di chiusura:
4.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.02
Aprire:
$3.93
Volume 24 ore:
2.31M
Relative Volume:
1.00
Capitalizzazione di mercato:
$369.90M
Reddito:
-
Utile/perdita netta:
$-48.17M
Rapporto P/E:
-7.2632
EPS:
-0.57
Flusso di cassa netto:
$-37.10M
1 W Prestazione:
-4.61%
1M Prestazione:
+13.58%
6M Prestazione:
-48.44%
1 anno Prestazione:
-51.06%
Intervallo 1D:
$3.87
$4.22
Intervallo di 1 settimana:
$3.66
$4.58
Portata 52W:
$2.86
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corporation
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Confronta AVXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
4.14 | 359.18M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Anavex Life Sciences (AVXL) Projected to Post Quarterly Earnings on Monday - Defense World
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease - marketscreener.com
Anavex (NASDAQ: AVXL) to seek CHMP re-exam after EU negative view on blarcamesine - Stock Titan
How does Anavex Life Sciences Corporation (AVXL) change from a tortoise to a hare? - Setenews
Is Anavex Life Sciences Corp. stock a defensive play in 2025Market Risk Analysis & Growth Focused Stock Reports - Newser
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm - The AI Journal
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm - Benzinga
Marvell Posts Strong Q3 Earnings, Joins American Eagle, Microchip Technology, Box And Other Big Stocks Moving Higher On Wednesday - Benzinga
Down 50.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Anavex Life Sciences (AVXL) - Finviz
Can Anavex Life Sciences Corp. (12X1) stock sustain institutional flowsMarket Risk Summary & Technical Buy Zone Confirmations - Newser
Anavex Life Sciences: Negative CHMP Decision Does Not Bode Well For Future Approval For Alzheimer's - Seeking Alpha
Check Out Anavex Life Sciences Corporation (AVXL)’s Trade Data Rather Than the Analysts’ Views - Setenews
What analysts say about Anavex Life Sciences Corp stockEarnings Miss Alerts & Superior Capital Trading - earlytimes.in
Why Anavex Life Sciences Corp. stock could rally in 2025July 2025 Sector Moves & Low Risk High Reward Ideas - BỘ NỘI VỤ
D. Boral Capital Reaffirms Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences’ (AVXL) Buy Rating Reiterated at D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Earns “Buy” Rating from D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at D. Boral Capital - Defense World
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Anavex Life Sciences And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Anavex (NASDAQ: AVXL) to present blarcamesine Phase IIb/III Alzheimer’s results at CTAD - Stock Titan
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Anavex Life Sciences Corp (AVXL) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Anavex Life Sciences Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2025 - MarketScreener
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update - MarketScreener
Anavex Life Sciences (NASDAQ: AVXL) Quarter 2025 Reports $102.6M, Three-Year Runway - Stock Titan
You might want to take a look at Anavex Life Sciences Corporation (AVXL) now - Setenews
Anavex Life Sciences (AVXL) Expected to Announce Earnings on Tuesday - Defense World
Will Anavex Life Sciences Corp. stock rally after Fed decisions2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com
Can Anavex Life Sciences Corp. stock maintain operating marginsWeekly Trade Review & Detailed Earnings Play Alerts - newser.com
How Anavex Life Sciences Corp. (12X1) stock trades after rate cuts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - cnhinews.com
Anavex Life Sciences Corp. to Release Fiscal Year End Financial Results on November 25, 2025 - Quiver Quantitative
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 - marketscreener.com
Anavex Life Sciences (Nasdaq: AVXL) to Report Fiscal 2025 Results on Nov. 25 - Stock Titan
A significant driver of top-line growth: Anavex Life Sciences Corporation (AVXL) - Setenews
Why Anavex Life Sciences (AVXL) Is Down 43.8% After EMA Setback for Lead Alzheimer’s Drug - Yahoo Finance
Can Anavex Life Sciences Corp. stock deliver strong Q4 earnings2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Is Anavex Life Sciences Corp. stock resilient to inflationWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
Will Anavex Life Sciences Corp. (12X1) stock rise with strong economyJuly 2025 Opening Moves & Pattern Based Trade Signal System - newser.com
Anavex Life Sciences Shares Plummet Following EU Regulatory Setback - StocksToTrade
Anavex Life Sciences Stock Plummets Amid Regulatory Hurdles - StocksToTrade
How strong is Anavex Life Sciences Corp. stock revenue growthQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Will Anavex Life Sciences Corp. (12X1) stock deliver compounding returns2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
Can Anavex Life Sciences Corp. stock attract ESG capital inflowsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
Anavex Life Sciences Corp. (AVXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Anavex Life Sciences (NASDAQ:AVXL) Reaches New 12-Month LowHere's Why - MarketBeat
Real time breakdown of Anavex Life Sciences Corp. stock performance2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Micron Tech, Netflix among market cap stock movers on Friday By Investing.com - Investing.com UK
Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):